Pegilodecakin for metastatic kidney cancer
Combinations of immunotherapy and vascular endothelial growth factor (VEGF) inhibitors [...]
Effect of antibiotics on outcomes with systemic treatments for metastatic kidney cancer
The microbes in the gut (the gut microbiome) are a [...]
Computer-designed interleukin 2 (IL 2) without the side effects?
Interleukin-2 (IL2) is a naturally-occurring biological therapy called a cytokine. [...]
Anticancer immunotherapy that overcomes tumour resistance to immune checkpoint inhibitors
Despite some remarkable patient outcomes in recent years, most tumours [...]
